Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 09:05:19 15/05/2024 pm IST			5-day change	1st Jan Change
0.315 ^EUR	-4.26%		-5.12%	-12.50%

17/04	Intrasense: an innovative solution for cancer monitoring	CF
09/04	Guerbet: CE certificate for a platform	CF

Intrasense : Remise en œuvre du contrat de liquidité conclu avec TSAF

June 09, 2023 at 09:22 pm IST

Remise en œuvre du contrat de liquidité conclu avec TSAF

09 Jun 2023 17:45 CEST

Issuer

INTRASENSE

cpremise-contrat-liquidite.pdf

Source

INTRASENSE

Provider

Euronext

Company Name

INTRASENSE

ISIN

FR0011179886

Symbol

ALINS

Market

Euronext Growth

Attachments

Original Link
Original Document
Permalink

Disclaimer

Intrasense SA published this content on 09 June 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 June 2023 15:51:06 UTC.

Latest news about Intrasense

Intrasense: an innovative solution for cancer monitoring	17/04	CF
Guerbet: CE certificate for a platform	09/04	CF
Intrasense: awarded CE certificate	09/04	CF
Invest Securities Raises Intrasense PT, Maintains Neutral Rating	22/03	MT
INTRASENSE : Invest Securities adjusts its target	22/03	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	09/02	CF
Intrasense: 2023 sales down on China	09/02	CF
Guerbet: sales growth of 4% by 2023	09/02	CF
Intrasense Partners with Software Company EDL for Myrian Distribution	19/23/19	MT
Intrasense S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Invest Securities Downgrades Intrasense to Neutral from Buy	04/23/04	MT
INTRASENSE : Invest Securities downgrades its recommendation	04/23/04	CF
Guerbet wins prostate cancer challenge	17/23/17	CF
Guerbet: agreement on AI for medical imaging	19/23/19	CF
Intrasense: joins Guerbet Group following successful takeover bid	12/23/12	CF
Guerbet: Intrasense joins the group	12/23/12	CF
Guerbet: holds 56.5% of Intrasense following reopening of its offer	09/23/09	CF
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	05/23/05	CI
Global markets live: Micron, Qantas, Zoom, Meta, BT Group...	23/23/23
Guerbet: takeover bid for Intrasense to resume on May 23	22/23/22	CF
Guerbet: successful takeover bid for Intrasense	22/23/22	CF
Guerbet: takeover bid opened for Intrasense shares	06/23/06	CF
Guerbet: AMF gives the green light to the takeover bid for Intrasense	05/23/05	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI

Chart Intrasense

Duration

Period

More charts

Company Profile

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,200 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.

Sector

Advanced Medical Equipment & Technology

Calendar

11/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTRASENSE	-12.50%	17.87M
THERMO FISHER SCIENTIFIC	+12.85%	229B
DANAHER CORPORATION	+13.88%	195B
INTUITIVE SURGICAL, INC.	+18.39%	142B
BOSTON SCIENTIFIC CORPORATION	+28.78%	109B
SIEMENS HEALTHINEERS AG	+1.67%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+18.24%	54.33B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+7.04%	52.09B
AGILENT TECHNOLOGIES, INC.	+10.83%	45.15B
GE HEALTHCARE TECHNOLOGIES INC.	+5.94%	37.39B

Other Advanced Medical Equipment & Technology